Stock Market

Stock market news, analysis, and trading insights

₹64,326 Cr Order Book: Will NCC stock be able to cross the ₹200 mark? Check the details

₹64,326 Cr Order Book: Will NCC stock be able to cross the ₹200 mark? Check the details

Synopsis: The stock has corrected nearly 42% in one year despite a strong ₹64,326 crore order book and 31% growth in inf...

By Alex Smith 6 months ago 3 min read
Why did Infosys profits decline despite an increase in revenues?

Why did Infosys profits decline despite an increase in revenues?

Synopsis: Infosys Ltd’s Q3 FY26 revenue rose 9% YoY to Rs. 45,479 cr, but net profit fell 2% to Rs. 6,666 cr due to a on...

By Alex Smith 6 months ago 4 min read
Angel One vs Groww: Which is a better buy according to Citi?

Angel One vs Groww: Which is a better buy according to Citi?

Synopsis: Citi initiated covering Angel One and Groww, assigning both a “Buy” rating. However, it sees more upside for A...

By Alex Smith 6 months ago 3 min read
Stocks to Buy: Tata Group and 7 Other Stocks Where UBS Sees Up to 88% Upside

Stocks to Buy: Tata Group and 7 Other Stocks Where UBS Sees Up to 88% Upside

Synopsis: UBS picks eight stocks, including Shaily Engineering, Max Healthcare, Indian Hotels, and Delhivery, citing str...

By Alex Smith 6 months ago 6 min read
3 Stocks in which DIIs increased their stake in Q3 to keep on your radar

3 Stocks in which DIIs increased their stake in Q3 to keep on your radar

Synopsis:- Domestic institutional investors raised their holdings in Q3FY26, increasing stakes by 0.4–1.2% across agri-F...

By Alex Smith 6 months ago 3 min read
Jio Financial, Angel One and 9 other stocks announcing Q3 results today

Jio Financial, Angel One and 9 other stocks announcing Q3 results today

Synopsis: Several major companies, including Jio Financial, HDFC Life, 360 ONE WAM, and Angel One, along with seven othe...

By Alex Smith 6 months ago 5 min read
Is 2026 a turning point for Divis Laboratories? Here’s what Citi says about the pharma stock

Is 2026 a turning point for Divis Laboratories? Here’s what Citi says about the pharma stock

Synopsis: Divis Laboratories is in focus after CITI expects its share price to rise by another 44% on the back of new la...

By Alex Smith 6 months ago 4 min read
Hospital stock in which LIC bought fresh stake in Q3 FY26; Do you hold it?

Hospital stock in which LIC bought fresh stake in Q3 FY26; Do you hold it?

Synopsis:- The company saw a notable institutional entry with a 1.09% stake acquired in December 2025. It operates 73 ho...

By Alex Smith 6 months ago 3 min read
CAMS and 4 other smallcap stocks in which FIIs have been reducing stakes for 3 quarters

CAMS and 4 other smallcap stocks in which FIIs have been reducing stakes for 3 quarters

Synopsis: FIIs are steadily reducing exposure to select small-cap stocks, including CAMS, PG Electroplast, BEPL, Choice...

By Alex Smith 6 months ago 4 min read
325% in 6 Months: How Monolithisch India Targets 5x Profit Growth by FY28?

325% in 6 Months: How Monolithisch India Targets 5x Profit Growth by FY28?

Synopsis: After delivering 325% returns in six months from listing price, Monolithisch India is scaling capacity from 1,...

By Alex Smith 6 months ago 6 min read
Shadowfax IPO: Flipkart backed issue opens on Jan 20, check the price band, financials and more

Shadowfax IPO: Flipkart backed issue opens on Jan 20, check the price band, financials and more

Synopsis: Shadowfax Technologies has set its IPO price band at ₹118–124 per share for its ₹1,907 crore public offering,...

By Alex Smith 6 months ago 4 min read
₹1 Lakh Cr Capex Plan: How Torrent Power Is Betting on Solar, Thermal and Hydrogen

₹1 Lakh Cr Capex Plan: How Torrent Power Is Betting on Solar, Thermal and Hydrogen

Synopsis:- A near ₹1 lakh crore capex plan targets expansion across thermal, renewables, storage, and green hydrogen. Ca...

By Alex Smith 6 months ago 4 min read